mesolimbic pathway

The following structures are considered to be a part of the mesolimbic pathway:

It has also been shown to significantly enhance dopamine activity in the mesolimbic pathway.

Particular attention has been paid to the function of dopamine in the mesolimbic pathway of the brain.

The contemporary medical model attributes addiction, in part, to changes in the brain's mesolimbic pathway.

The mesolimbic pathway is a dopaminergic pathway in the brain.

Excessive dopamine in the mesolimbic pathways of the brain produces psychotic symptoms.

Excess release of dopamine in the mesolimbic pathway has been linked to psychotic experiences.

There is evidence for increased activity of the mesolimbic pathway, a dopaminergic pathway, in schizophrenia patients.

Increased dopaminergic functional activity, specifically in the mesolimbic pathway, is found in schizophrenic individuals.

Virtually all drugs causing drug addiction increase the dopamine release in the mesolimbic pathway, in addition to their specific effects.

These neurons also project and release DA into the nucleus accumbens, through the mesolimbic pathway.

It also represents a part of the mesolimbic pathway, carrying information between the ventral tegmentum and the nucleus accumbens.

The desired clinical effect of reducing psychotic symptoms is thought to be associated with blocking dopamine function in the mesolimbic pathway only.

The mesolimbic pathway is one of the dopaminergic pathways in the brain that modulates behavioral responses to rewarding stimuli.

The large mesolimbic pathway projects primarily to the NAC and the olfactory tubercle.

It is still thought that dopamine mesolimbic pathways may be hyperactive, resulting in hyperstimulation of D receptors and positive symptoms.

Staining in the striatum and nucleus accumbens of the mesolimbic pathway was dense and heterogeneous.

The two primary efferent fiber projections of the VTA are the mesocortical and the mesolimbic pathways.

Guilt and passion activate the mesolimbic pathway, and indignation and disgust are activated by the amygdala.

In studying the causes of schizophrenia, particular focus has been placed upon the function of dopamine in the mesolimbic pathway of the brain.

This pathway is closely associated with the mesolimbic pathway, which is also known as the mesolimbic reward pathway.

When this pathway is disinhibited, an increase in the dopamine release in the mesolimbic pathway amplifies locomotor activity.

Almost all drugs causing drug addiction increase the dopamine release in the mesolimbic pathway, e.g. opioids, nicotine, amphetamine, ethanol and cocaine.

One such neurotransmitter is dopamine, a chemical messenger heavily active in the Mesolimbic pathway and Mesocortical pathway reward pathways.

The mesolimbic pathway contains the VTA, nucleus accumbens, amygdalae, and the medial prefrontal cortex.